We anticipate that the rate of identification of germline BRCA1 and BRCA2 mutation carriers will rapidly increase as we move towards new models of genetic testing in BC designed to accelerate the time to genetic diagnosis. The gene discussed is BRCA1; the disease is breast cancer.